Trial intelligence / Profile preview

Esketamine plus propofol anesthesia for hysteroscopic surgery (dose comparison vs sufentanil)

ChiCTR2400092022Phase 4Recruiting

Sponsor
Wenzhou People's Hospital
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine (4 arms), sponsored by Wenzhou People's Hospital. Primary endpoints: Pain score (NRS) and Dosage of propofol. Started Nov 2024; status: recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2400092022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400092022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call